Read More Pharma Industry News Vyriad and Merck launch Phase 1 trial for innovative immuno-oncology drug combination Vyriad, a US-based biotech company, has partnered with Germany’s Merck to initiate a Phase 1 clinical trial targeting… bypharmanewsdailyJuly 18, 2018
